Author: Alexander Lee

Alexander is the founder and author of Microcaps.ca, a leading resource for investors interested in the micro-cap stock market. With a passion for uncovering hidden gems in the world of small-cap stocks, Alexander combines in-depth research with years of experience in the financial markets to provide readers with valuable insights and timely analysis. Investors should conduct their own research or consult with a qualified investment advisor before making any investment decisions. The author of this article is not responsible for any gains or losses incurred from investing in companies mentioned.

Calian Group, a company based in Ontario and listed on the TSX under the symbol CGY, has been selected to provide a third high-performance antenna to NASA’s Goddard Space Flight Center for its space geodesy project. This 12-meter antenna will be utilized for NASA’s Very Long Baseline Interferometry (VLBI) Global Observing System (VGOS). The antenna supplied by Calian’s subsidiary InterTronic will support NASA’s Space Geodesy project, which oversees the maintenance of global geodetic infrastructure, including the VGOS network of antennas. Following the acquisition of InterTronic in 2021, Calian describes the subsidiary as a leading provider of high-performance antennas with state-of-the-art,…

Read More

Patriot Battery Metals (TSX-V: PMET) has announced the appointment of Ken Brinsden, former managing director and CEO of Pilbara Minerals (ASX: PLS), as its new non-executive chairperson and director. With over 30 years of experience in surface and underground mining, Mr. Brinsden has held key positions in major mining companies such as WMC Resources, Normandy, GoldFields, and Iluka Resources (ASX: ILU), among others. Mr. Brinsden’s extensive experience in production, development, and executive roles makes him a valuable addition to Patriot Battery Metals. CEO Blair Way expressed excitement about Mr. Brinsden joining the company, citing his success in building Pilbara Minerals…

Read More

PharmaDrug Inc (CSE: PHRX) has established the foundation to support the production of multi-kilograms of cepharanthine-2HCL for the final drug production of PD-001, aiming to treat responsive cancers and COVID-19. PD-001 is a patented oral and bioavailable version of cepharanthine developed by the Toronto-based pharmaceutical company. Cepharanthine is a natural product and an approved drug with over 70 years of use in Japan, demonstrating efficacy in treating various acute and chronic diseases. An important milestone was achieved by PharmaDrug through the completion of sourcing and characterisation of bulk materials, preparation of reference standards, and qualification of necessary analytical methodologies. This…

Read More

First Hydrogen (TSX-V: FHYD) is focused on expanding its green hydrogen production operations in the North American market, with plans to establish key production sites in Canada and the US. The company has already begun development on four green hydrogen production sites in the UK and is now turning its attention to North America. First Hydrogen Energy, the energy division of First Hydrogen, is initially targeting Canada for its operations. The country’s abundant renewable energy resources, such as hydropower, solar, and wind, make it an ideal location for producing green hydrogen without carbon emissions. Additionally, recent policy changes in Canada…

Read More

TC Energy, a prominent energy company in North America, recently announced a partnership with Mexico’s state-owned electric utility Comisión Federal de Electricidad (CFE) to develop a US$4.5 billion natural gas pipeline known as the offshore Southeast Gateway Pipeline. This project aims to supply natural gas to regions in central and southeast Mexico, providing clean and reliable energy to millions of people. TC Energy is committed to finding sustainable solutions to move, generate, and store energy that North America relies on. The Southeast Gateway Pipeline is expected to be a 1.3 billion cubic feet per day, 715-kilometre offshore natural gas pipeline.…

Read More

Spark Power Group’s solar O&M business, listed on the TSX as SPG, has recently entered into a long-term agreement with 174 Power Global for the Rayos Del Sol Solar project located in Texas. Rayos Del Sol Solar project is owned by 174 Power Global, a subsidiary of the Hanwha Group, a prominent leader in solar and energy storage project developments. According to the agreement, Spark Power will provide comprehensive operational and maintenance support to the Rayos Del Sol Solar project. Richard Jackson, President, and CEO of Spark Power expressed his excitement about the partnership and the opportunity to work with…

Read More

Algernon Pharmaceuticals, a Canadian drug development company in the clinical stage, has announced that they will be presenting the results of their phase 2a study on NP-120 (Ifenprodil) for the treatment of idiopathic pulmonary fibrosis (IPF) and chronic cough at the upcoming American Cough Conference. Ifenprodil is an N-methyl-D-aspartate (NMDA) receptor antagonist that targets the NMDA-type subunit 2B (GluN2B), thereby inhibiting glutamate signaling. This innovative treatment represents a first-in-class option for patients with IPF and chronic cough. The American Cough Conference serves as a biennial educational platform for healthcare professionals engaged in cough research and management. Dr. Peter Dicpinigaitis, the…

Read More

Optimi Health (CSE: OPTI) has recently introduced Blue Serenity, the first natural therapeutic psilocybin product in Canada, in collaboration with psilocybin patient advocate, Thomas Hartle. Blue Serenity contains 25 milligrams of natural psilocybin in the form of EU-GMP biomass grown as Panaeolus cyanescens mushrooms, which were cultivated at Optimi Health’s facilities in Princeton, British Columbia. Optimi’s chief science officer, Justin Kirkland, and head of cultivation, Todd Henderson, partnered with Mr. Hartle to develop a specific genetic strain based on his therapeutic experiences. The partnership was announced on August 8, with Optimi Health expressing its commitment to producing a Canadian-grown and…

Read More

TraceSafe (CSE: TSF) has unveiled its carbon management platform, ShiftCarbon, designed to support organizations in achieving carbon neutrality and net zero goals. This platform represents TraceSafe’s largest launch since the introduction of AllSafe, an acclaimed enterprise safety platform. Wayne Lloyd, CEO of TraceSafe, emphasized that ShiftCarbon enables organizations to accurately measure their carbon neutrality and net zero efforts. In response to the increasing pressure from stakeholders to decarbonize, TraceSafe is providing solutions to help organizations navigate their journey towards net zero. ShiftCarbon integrates advanced technology and services to gather emissions data and identify offset opportunities on a flexible platform. The…

Read More

Converge Technology Solutions (TSX: CTS) has successfully completed the acquisition of PC Specialists Technology Integration Group (TIG) after entering into an agreement in May of this year. TIG, headquartered in San Diego, is a comprehensive IT service provider with 20 offices across North America offering performance optimization solutions and essential business support. Their range of services includes software and hardware procurement, discovery assessments, strategic planning, deployment, data center optimization, IT asset management, and cloud computing, as well as customized IT solutions for clients worldwide. This acquisition marks Converge’s 31st purchase since October 2017, adding to their growing portfolio of companies…

Read More